New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

A study involving researchers from Karolinska Institutet indicates that prostate cancer can be diagnosed at an early stage ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

Abstracts presented at this year's American Urological Association (AUA) Annual Meeting in Las Vegas will spotlight a series ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

Clarius Mobile Health, a pioneer in AI-powered handheld ultrasound, is introducing Clarius Prostate AI, an FDA cleared semi-automatic tool that quickly and accurately calculates prostate volume during ...

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

"It is very reassuring," said study author Recinda Sherman, PhD, MPH, of the North American Association of Central Cancer ...